Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥11.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥210m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥343m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥203m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥889m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥339m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥79m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥339m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥613m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥249m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥7.7bnat 2022-09-30Cons.Assets
Total assets¥8.6bnat 2022-03-31Cons.Assets
Total assets¥8.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥2.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥2.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.6bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥45m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥291m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥31m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥151m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥48m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥371m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥696m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥326m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1.142022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.712022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.112021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥92.512021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio26.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥116m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥752m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥746m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥70m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥868m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥867m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥233m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥103,000
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥173m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥591m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥582m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥51m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥170m
—segment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
—segment totalsegment profit2021-04-01 → 2021-09-30¥395m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥395m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Income before income taxesPrior1YTDDuration338611000JPY
Income before income taxesCurrentYTDDuration79313000JPY
Income taxes currentPrior1YTDDuration65368000JPY
Income taxes currentCurrentYTDDuration34629000JPY
Income taxes deferredPrior1YTDDuration24499000JPY
Income taxes deferredCurrentYTDDuration41626000JPY
Income taxesPrior1YTDDuration89867000JPY
Income taxesCurrentYTDDuration76256000JPY
Profit lossPrior1YTDDuration248743000JPY
Profit lossCurrentYTDDuration3056000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration248743000JPY
Profit loss attributable to owners of parentCurrentYTDDuration3056000JPY
Profit lossPrior1YTDDuration248743000JPY
Profit lossCurrentYTDDuration3056000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration5749000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-JPY
Other comprehensive incomePrior1YTDDuration5749000JPY
Other comprehensive incomeCurrentYTDDuration-JPY
Comprehensive incomePrior1YTDDuration254493000JPY
Comprehensive incomeCurrentYTDDuration3056000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration254493000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3056000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration338611000JPY
Income before income taxesCurrentYTDDuration79313000JPY
Depreciation and amortization ope cfPrior1YTDDuration30898000JPY
Depreciation and amortization ope cfCurrentYTDDuration30572000JPY
Amortization of goodwill ope cfPrior1YTDDuration186381000JPY
Amortization of goodwill ope cfCurrentYTDDuration184986000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-1048000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-1398000JPY
Interest and dividends income ope cfPrior1YTDDuration-143000JPY
Interest and dividends income ope cfCurrentYTDDuration-137000JPY
Interest expenses ope cfPrior1YTDDuration15106000JPY
Interest expenses ope cfCurrentYTDDuration12112000JPY
Gain on business transfer ope cfPrior1YTDDuration-5737000JPY
Gain on business transfer ope cfCurrentYTDDuration-JPY
Loss on reversal of foreign currency translation adjustments ope cfPrior1YTDDuration5749000JPY
Loss on reversal of foreign currency translation adjustments ope cfCurrentYTDDuration-JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration79000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration284000JPY
Borrowing fee ope cfPrior1YTDDuration30000JPY
Borrowing fee ope cfCurrentYTDDuration-JPY
Special survey costs etc ope cfPrior1YTDDuration-JPY
Special survey costs etc ope cfCurrentYTDDuration122916000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration137261000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration401115000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass